Bunaftine

This classification denotes an antiarrhythmic agent with the molecular formula C21H30N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) GH09PRQ3FU, chemically known as 1-naphthalenecarboxamide, n-butyl-n-(2-(diethylamino)ethyl)- but more generally known as bunaftine, which bears US NIH Compound Identifier 36131. European Medicines Agency schedules Bunaftine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05973MIG. The term BUNAFTINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules bunaftine in its Anatomical Therapeutic Chemical (ATC) Classification. BUNAFTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule bunaftine under HS 29242995 and SITC 51479. As of Q4 2014, BUNAFTINE remains US FDA's Preferred Term for this commodity. Bunaftine bears US NLM identifiers UMLS ID C0006378 and NCI Concept Code C72578. SMILES: O=C(N(CCN(CC)CC)CCCC)C1C2C(CCC1)CCCC2.